Family Medicine

Association with familial history found in hospitalizations, suicide attempts, and an earlier onset of symptoms.

The monitor is approved for children and adults 4 years and older with diabetes.

The intervention model can be used to help manage a variety of chronic diseases.

Survey findings highlight the psychological and psychosocial distress related to having diabetes.

More patients achieve international time in range consensus target of greater than 70% with the Advanced system.

The drug reduces the time to improvement of flu symptoms in patients having at least 1 high-risk factor.

Time of cannabis use can predict larger decreases in intrusions and irritability in individuals suffering from PTSD.

Between 2002-2019, NASH is the leading liver indication for women without HCC.

Recent studies show efficacy and safety for both lemborexant and ozanimod.

A new paper highlights the means by which child healthcare, a "human science," will rebound from the pandemic.

A new retrospective chart review is examining effectiveness of nitrous oxide during labor and potential predictors to conversion to other therapies.

Other treatment plans need to be considered for women with anxiety or insomnia.

High-potency cannabis use led to an increase in cannabis use frequency, as well as cannabis problems.

Investigators expect an increase in demand for mental health services for young people in the coming years.

More prospective studies are needed to examine how different drugs can be effective for schizophrenia patients based on the cluster of symptoms.

Guidelines are needed to better understand who needs the test.

Antipsychotic discontinuation remains a major hurdle for effective schizophrenia treatment.

The tau tracer can support a pathological diagnosis of Alzheimer disease by identifying the underlying presence of NFTs at the B3 level.

Currently, the use of minocycline is limited orally due to some systemic side effects.

Researchers are continuing to learn how the COVID-19 virus will effect patients with inflammatory bowel disease.

In a new study, investigators discover insomnia severity could predict first-onset major depressive disorder.

The new technology has applications for diagnosis and recruitment for disease-modifying trials.

In the latest edition of the DocTalk Podcast, Dr. Mark Smith talks about some of the issues related to the COVID-19 lockdown and how a second wave might psychologically impact individuals.

The findings can lead physicians to stop prescribing the drug.

The newest indication for the add-on biologic grants it use in children aged 6-11 years old with moderate to severe, uncontrolled atopic dermatitis.